Skip to main content
SpringerLink
Log in

Metabolic Syndrome—Past and Future

An Introduction to the Features of This Book

  • Chapter
Book cover The Metabolic Syndrome

Part of the book series: Contemporary Endocrinology ((COE))

  • 1597 Accesses

Abstract

This volume is a review by clinicians and researchers of the broad spectrum of research on the metabolic syndrome and its underlying disturbed pathways. It provides insights useful in understanding some of the features and processes in the development of diabetes and cardiovascular disease. Although there are differences of opinion about the value of the metabolic syndrome, it has one important aspect: It focuses attention on clinical considerations related to diabetes and heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens 2006; 24(4):621–626.

    Article  CAS  PubMed  Google Scholar 

  2. Vague J, Vague P, Jubelin J. A 35-year follow-up of diabetogenic obesity. Int J Obes 1987; 11(suppl 2):38.

    Google Scholar 

  3. Vague 1. La dijferentiation sexuelle: Facteur determinant des formes de l’obesite. See http:// www.obesityresearch.org/cgi/reprint/l0/l/14.pdf. Presse Med 1947; 55:339–341.

    CAS  Google Scholar 

  4. Vague 1. La dijferenciation sexuelle humaine: Ses incidences en pathologie. Masson, Paris, 1953; reprinted in http://www.blackwell-synergy.comllinks/doi/l0.llll/j.1467-3010.2004.00403.x/ enhancedabs/WHO (World Health Organization1999 Report, p. 386).

    Google Scholar 

  5. Vague J. The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4(1):20–34.

    CAS  PubMed  Google Scholar 

  6. Vague J et al. Forms of obesity and metabolic disorders. Verh Dtsch Ges Inn Med 1987; 93:448–462.

    CAS  PubMed  Google Scholar 

  7. Camus JP. Gout, diabetes, hyperlipemia: A metabolic trisyndrome. Rev Rhum Mal Osteoartic 1966; 33(1): 10–14.

    CAS  PubMed  Google Scholar 

  8. Welborn TA et al. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet 1966; 1(7451):1336–1337.

    Article  CAS  PubMed  Google Scholar 

  9. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2(2):154–160.

    Article  CAS  PubMed  Google Scholar 

  10. Modan M et al. Hyperinsulinemia: A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75(3):809–817.

    Article  CAS  PubMed  Google Scholar 

  11. Modan M et al. Elevated serum uric acid: A facet of hyperinsulinaemia. Diabetologia 1987; 30(9):713–718.

    Article  CAS  PubMed  Google Scholar 

  12. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care 1979; 2(2): 131–141.

    Article  Google Scholar 

  13. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595–1607.

    Article  CAS  PubMed  Google Scholar 

  14. DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14(3):173–194.

    Article  CAS  PubMed  Google Scholar 

  15. Florez H et al. Women relatives of Hispanic patients with type 2 diabetes are more prone to exhibit metabolic disturbances. Invest Clin 1999; 40(2):127–142.

    CAS  PubMed  Google Scholar 

  16. Foster DW. Insulin resistance: A secret killer? N Engl J Med 1989; 320(11):733–734.

    Article  CAS  PubMed  Google Scholar 

  17. Hayashi H et al. Contribution of a missense mutation (Trp64Arg) in beta3-adrenergic receptor gene to multiple risk factors in Japanese men with hyperuricemia. Endocr J 1998; 45(6):779–784.

    Article  CAS  PubMed  Google Scholar 

  18. Lempiainen P et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999; 100(2):123–128.

    CAS  PubMed  Google Scholar 

  19. Liese AD et al. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort: World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999; 10(4):391–397.

    Article  CAS  PubMed  Google Scholar 

  20. Crepaldi G, Nosadini R. Diabetic cardiopathy: Is it a real entity? Diabetes Metab Rev 1988; 4(3):273–288.

    Article  CAS  PubMed  Google Scholar 

  21. Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149(7):1514–1520.

    Article  CAS  PubMed  Google Scholar 

  22. Zimmet P. The epidemiology of diabetes mellitus and related conditions. In: The Diabetes Annual/6, Alberti K, Krall LP (eds.), 1991, Elsevier, Amsterdam.

    Google Scholar 

  23. Eriksson J, Taimela S, Koivisto VA. Exercise and the metabolic syndrome. Diabetologia 1997; 40(2): 125–135.

    Article  CAS  PubMed  Google Scholar 

  24. Scott R et al. Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus? Diabetes Research and Clinical Practice 1999, March; 43(Issue 3):179–185.

    Article  CAS  PubMed  Google Scholar 

  25. Shafrir E. Animal models of syndrome X. Current Topics in Diabetes Research 1993; 12: 165–181.

    CAS  Google Scholar 

  26. Kahn R et al. The metabolic syndrome: Time for a critical appraisal-joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28(9):2289–2304.

    Article  PubMed  Google Scholar 

  27. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7):539–553.

    Article  CAS  PubMed  Google Scholar 

  28. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16(5):442–443.

    Article  CAS  PubMed  Google Scholar 

  29. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19):2486–2497.

    Google Scholar 

  30. Einhorn D et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9(3):237–252.

    PubMed  Google Scholar 

  31. Federation ID. The IDF Consensus Worldwide Definition of Metabolic Syndrome, April 14, 2005, http://www.idf.org/webdataldocs/IDF_Metasyndrome_definition. pdf.

    Google Scholar 

  32. Grundy SM et al. Diagnosis and management of the metabolic syndrome: An American Heart AssociationlNational Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112(17):2735–2752.

    Article  PubMed  Google Scholar 

  33. Hollenbeak CS et al. Predicting the prevalence of cardiometabolic risk factors when clinical data are limited. Value Health 2007; 10(suppl 1):S4–S11.

    Article  Google Scholar 

  34. Lin SX, Pi-Sunyer EX. Prevalence of the metabolic syndrome among US middle-aged and older adults with and without diabetes: A preliminary analysis of the NHANES 1999–2002 data. Ethn Dis 2007; 17(1):35–39.

    PubMed  Google Scholar 

  35. Barri YM. Hypertension and kidney disease: A deadly connection. Curr Cardiol Rep 2006; 8(6):411–417.

    Article  PubMed  Google Scholar 

  36. Koopman RJ et al. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes. Ann Fam Med 2006; 4(5):427–432.

    Article  PubMed  Google Scholar 

  37. Tjepkema M. Adult obesity. Health Rep 2006; 17(3):9–25.

    PubMed  Google Scholar 

  38. Thorpe KE, Florence CS, Joski P. Which medical conditions account for the rise in health care spending? Health Aff (Millwood) 2004; Suppl Web Exclusives:W4-437-445.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obesity, Diabetes, and Aging Research Center, University of South Florida College of Medicine, Tampa, FL

    Barbara Caleen Hansen PhD (Professor of Internal Medicine and Pediatrics, Director)

  2. Writer and Coordinator, Baltimore, MD

    Rosemary Peternel

  3. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA

    George A. Bray MD (Boyd Professor)

Authors
  1. Barbara Caleen Hansen PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosemary Peternel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George A. Bray MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Obesity, Diabetes, and Aging Research Center, University of South Florida College of Medicine, Tampa, FL

    Barbara Caleen Hansen PhD (Professor of Internal Medicine and Pediatrics Director) (Professor of Internal Medicine and Pediatrics Director)

  2. Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA

    George A. Bray MD (Boyd Professor) (Boyd Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Hansen, B.C., Peternel, R., Bray, G.A. (2008). Metabolic Syndrome—Past and Future. In: Hansen, B.C., Bray, G.A. (eds) The Metabolic Syndrome. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-116-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-116-5_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-738-9

  • Online ISBN: 978-1-60327-116-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation